Jeffrey S. Smith
Auburn University
H-index: 35
North America-United States
Top articles of Jeffrey S. Smith
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Can Hypotonic Saline Cough Challenge Help Us to Understand Mechanisms of Cough in Idiopathic Pulmonary Fibrosis? | J King J Wingfield Digby S Galgani J Mitchell R Dockry | 2024/5 | |
Nalbuphine Extended-release Reduces Cough Bouts in Patients With Idiopathic Pulmonary Fibrosis | J Smith K Carroll D Clark PL Molyneaux | 2024/5 | |
Camlipixant Reduces Burden of Cough-related Urinary Incontinence in Patients With Refractory Chronic Cough in Post-hoc Analysis of A Phase 2b Trial | VN Iyer P Dicpinigaitis R Taliercio SS Birring J Smith | 2024/5 | |
Development of the McMaster Cough Severity Questionnaire (MCSQ): A Cough Severity Instrument for Patients With Chronic Cough | E Kum G Guyatt R Abdulqawi P Dicpinigaitis L Dupont | 2024/5 | |
Randomized Proof-of-concept Study of AX-8, a TRPM8 Agonist, in Refractory or Unexplained Chronic Cough | J Smith J Hull SS Birring AH Morice S Parker | 2023/5 | |
P115. Utilization of TXA in ASD patients with potential contraindications for TXA does not lead to increased thromboembolic complications: critical information for surgical and … | The Spine Journal | Jeffrey Mullin Jeffrey Gum Mohamed Soliman Breton Line Shay Bess | 2023/9/1 |
Lower leg power and grip strength are associated with increased fall injury risk in older men: the osteoporotic fractures in men study | The Journals of Gerontology: Series A | Mary E Winger Paolo Caserotti Jane A Cauley Robert M Boudreau Sara R Piva | 2023/3/1 |
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study | The Lancet Respiratory Medicine | Callum Jackson Iain D Stewart Tatiana Plekhanova Peter S Cunningham Andrew L Hazel | 2023/8/1 |
EFFECTS OF TRAINING AND SEX ON EXPIRATORY FLOW LIMITATION PREVALENCE AND SEVERITY IN YOUTH CYCLISTS | International Journal of Exercise Science: Conference Proceedings | W Burton S Ridgeway K Cox J Smith N Luden | 2023 |
The power of genetic diversity in genome-wide association studies of lipids (vol 600, pg 675, 2021) | Nature | Sarah E Graham Shoa L Clarke Kuan-Han H Wu Stavroula Kanoni Greg JM Zajac | 2023/5/26 |
Response in patient-reported cough severity in soothe, a phase 2b trial of camlipixant in refractory chronic cough | Lorcan Mcgarvey J Smith SS Birring P Dicpinigaitis MR Sher | 2023/5 | |
Effectiveness of enhanced performance feedback on appropriate use of blood transfusions: a comparison of 2 cluster randomized trials | JAMA Network Open | Simon J Stanworth Rebecca Walwyn John Grant-Casey Suzanne Hartley Lauren Moreau | 2022/2/1 |
Improvements in Cough Severity and Quality of Life in SOOTHE, A Phase 2b, Dose Finding Trial of BLU-5937 in Refractory Chronic Cough | SS Birring J Smith AH Morice L Mcgarvey MR Sher | 2022/5 | |
Split-dose administration enhances immune responses elicited by a mRNA/lipid nanoparticle vaccine expressing respiratory syncytial virus F protein | Molecular Pharmaceutics | Lauren A Austin Jeffrey S Smith Debbie D Nahas Andrew Danzinger Susan Secore | 2022/10/17 |
Engaging your college students: 30 tools you can use next week | J Smith | 2022 | |
Safety and efficacy of BLU-5937 in the treatment of refractory chronic cough from the phase 2b soothe trial | J Smith L Mcgarvey SS Birring AH Morice MR Sher | 2022/5 | |
Real world effectiveness and tolerability of low-dose opiates for refractory/unexplained chronic cough (RCC/UCC) in a tertiary clinic | J King J Wingfield-Digby S Hennessey A Woodcock J Smith | 2022/9/4 | |
Responders Analyses in Objective 24H Cough Frequency in Soothe, A Phase 2b Trial of a Selective P2x3 Antagonist in Refractory Chronic Cough | AH Morice J Smith SS Birring L Mcgarvey JH Hull | 2022/5 | |
Hypotonic saline effectively discriminates refractory/unexplained chronic cough from healthy volunteers | J Wingfield Digby J King R Dockry S Sen S Galgani | 2022/9/4 | |
Refractory chronic cough patients are indiscriminately hyper-responsive to inhaled tussive irritants/agents | J King B Al-Sheklly J Wingfield Digby S Sen J Mitchell | 2022/5 |
Co-Authors
